Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Nath R, Bice WS, Butler WM, Chen Z, Meigooni AS, Narayana V, Rivard MJ, Yu Y; American Association of Physicists in Medicine.

Med Phys. 2009 Nov;36(11):5310-22.

2.

The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.

Brenner DJ.

Semin Radiat Oncol. 2008 Oct;18(4):234-9. doi: 10.1016/j.semradonc.2008.04.004.

3.

High-dose single-fraction radiotherapy: exploiting a new biology?

Brown JM, Koong AC.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):324-5. doi: 10.1016/j.ijrobp.2008.02.003. No abstract available.

PMID:
18474308
4.

Combined use of Monte Carlo DNA damage simulations and deterministic repair models to examine putative mechanisms of cell killing.

Carlson DJ, Stewart RD, Semenenko VA, Sandison GA.

Radiat Res. 2008 Apr;169(4):447-59. doi: 10.1667/RR1046.1.

PMID:
18363426
5.

A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).

Drzymala RE, Wasserman TH, Won M, Shaw E, Cmelak AJ, Loeffler J, Souhami L; Radiation Therapy Oncology Group.

Radiother Oncol. 2008 Apr;87(1):89-92. doi: 10.1016/j.radonc.2008.02.006. Epub 2008 Mar 14.

PMID:
18342381
6.

The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

Lin Z, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J, Ling CC.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1219-28. doi: 10.1016/j.ijrobp.2007.09.050.

7.

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.

Park C, Papiez L, Zhang S, Story M, Timmerman RD.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059.

PMID:
18262098
8.

High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions.

Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):484-90. doi: 10.1016/j.ijrobp.2007.11.046. Epub 2008 Jan 30.

PMID:
18234445
9.

Optimum overall times II: Extended modelling for head and neck radiotherapy.

Fowler JF.

Clin Oncol (R Coll Radiol). 2008 Mar;20(2):113-26. Epub 2007 Dec 26.

PMID:
18155893
10.

Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?

Daşu A.

Clin Oncol (R Coll Radiol). 2007 Jun;19(5):289-301. Epub 2007 Mar 9. Review.

PMID:
17517328
12.

Comments on "Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer".

Daşu A, Fowler JF.

Phys Med Biol. 2005 Mar 21;50(6):L1-4; author reply L5-8. No abstract available.

PMID:
17001787
13.

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J.

Radiother Oncol. 2005 Oct;77(1):18-24. Epub 2005 Aug 10.

PMID:
16098619
14.

Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy.

Valdagni R, Italia C, Montanaro P, Lanceni A, Lattuada P, Magnani T, Fiorino C, Nahum A.

Radiother Oncol. 2005 Apr;75(1):74-82. Epub 2005 Apr 18.

PMID:
15878104
15.
16.

Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.

Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M.

Phys Med Biol. 2004 Oct 7;49(19):4477-91.

PMID:
15552412
17.

The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.

Hoskin PJ, Sibtain A, Daley FM, Saunders MI, Wilson GD.

Radiother Oncol. 2004 Aug;72(2):159-68.

PMID:
15297134
18.

Exploiting tumour hypoxia in cancer treatment.

Brown JM, Wilson WR.

Nat Rev Cancer. 2004 Jun;4(6):437-47. Review. No abstract available.

PMID:
15170446
19.

Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer.

Parker C, Milosevic M, Toi A, Sweet J, Panzarella T, Bristow R, Catton C, Catton P, Crook J, Gospodarowicz M, McLean M, Warde P, Hill RP.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):750-7.

PMID:
14967430
20.

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M.

Chest. 2003 Nov;124(5):1946-55.

PMID:
14605072

Supplemental Content

Support Center